» Articles » PMID: 39192971

Glioblastoma-derived Exosomes Promote Lipid Accumulation and Induce Ferroptosis in Dendritic Cells Via the NRF2/GPX4 Pathway

Overview
Journal Front Immunol
Date 2024 Aug 28
PMID 39192971
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma-derived exosomes (GDEs), containing nucleic acids, proteins, fatty acids and other substances, perform multiple important functions in glioblastoma microenvironment. Tumor-derived exosomes serve as carriers of fatty acids and induce a shift in metabolism towards oxidative phosphorylation, thus driving immune dysfunction of dendritic cells (DCs). Lipid peroxidation is an important characteristic of ferroptosis. Nevertheless, it remains unclear whether GDEs can induce lipid accumulation and lipid oxidation to trigger ferroptosis in DCs. In our study, we investigate the impact of GDEs on lipid accumulation and oxidation in DCs by inhibiting GDEs secretion through knocking down the expression of Rab27a using a rat orthotopic glioblastoma model. The results show that inhibiting the secretion of GDEs can reduce lipid accumulation in infiltrating DCs in the brain and decrease mature dendritic cells (mDCs) lipid peroxidation levels, thereby suppressing glioblastoma growth. Mechanistically, we employed treatments of bone marrow-derived dendritic cells (BMDCs) with GDEs. The results indicate that GDEs decrease the viability of mDCs compared to immature dendritic cells (imDCs) and trigger ferroptosis in mDCs via the NRF2/GPX4 pathway. Overall, these findings provide new insights into the development of immune-suppressive glioblastoma microenvironment through the interaction of GDEs with DCs.

Citing Articles

Regulation of Ferroptosis in Cancer and Immune Cells.

Jang N, Kim I, Jung D, Chung Y, Kang Y Immune Netw. 2025; 25(1):e6.

PMID: 40078787 PMC: 11896659. DOI: 10.4110/in.2025.25.e6.


Immune Cell Interplay in the Fight Against GBM.

Vallieri N, Datsi A Cancers (Basel). 2025; 17(5).

PMID: 40075663 PMC: 11899300. DOI: 10.3390/cancers17050817.


HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.

Han R, Luo Y, Gao J, Zhou H, Wang Y, Chen J Vaccines (Basel). 2025; 13(2).

PMID: 40006729 PMC: 11860249. DOI: 10.3390/vaccines13020182.


Tumor Metabolic Reprogramming and Ferroptosis: The Impact of Glucose, Protein, and Lipid Metabolism.

Zhu K, Cai Y, Lan L, Luo N Int J Mol Sci. 2025; 25(24.

PMID: 39769177 PMC: 11676715. DOI: 10.3390/ijms252413413.

References
1.
Kim R, Hashimoto A, Markosyan N, Tyurin V, Tyurina Y, Kar G . Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022; 612(7939):338-346. PMC: 9875862. DOI: 10.1038/s41586-022-05443-0. View

2.
Guo X, Qiu W, Liu Q, Qian M, Wang S, Zhang Z . Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways. Oncogene. 2018; 37(31):4239-4259. DOI: 10.1038/s41388-018-0261-9. View

3.
Morrissey S, Yan J . Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy. Trends Cancer. 2020; 6(7):550-558. PMC: 7330176. DOI: 10.1016/j.trecan.2020.03.002. View

4.
Danielli M, Perne L, Jovicic E, Petan T . Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death. Front Cell Dev Biol. 2023; 11:1104725. PMC: 9911892. DOI: 10.3389/fcell.2023.1104725. View

5.
Wang J, Liu P, Xin S, Wang Z, Li J . Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells. Exp Cell Res. 2017; 360(2):66-73. DOI: 10.1016/j.yexcr.2017.07.031. View